TABLE 3.
Event | Incidence, n (%) (n = 18 volunteers/treatment) |
||
---|---|---|---|
A (DRV/r) | B (RFB) | C (DRV/r + RFB) | |
Any adverse event | 5 (28) | 8 (44) | 15 (83) |
≥1 serious adverse event | 0 | 2 (11) | 2 (11) |
≥1 grade 3 or 4 adverse event | 0 | 2 (11) | 3 (17) |
≥1 adverse event leading to permanent discontinuation of trial medication | 0 | 2 (11) | 5 (28) |
Laboratory abnormalities | |||
≥1 worst grade 3 or 4 laboratory abnormality | 1 (6) | 9 (53) | 3 (17) |
≥1 laboratory abnormality leading to permanent discontinuation | 0 | 2 (11) | 0 |